Tumor-infiltrating lymphocyte 1 article

In biotechnology workflows, tumor-infiltrating lymphocyte functions as a tumor-derived lymphocyte therapy modality built around tumor-derived T cells. Its defining logic links TIL therapy and endogenous tumor-reactive lymphocytes with solid tumor immunotherapy, while tumor microenvironment T cells, autologous cell therapy and ex vivo lymphocyte expansion indicate the measurements, molecular events or applications most closely associated with the entity. For tumor-infiltrating lymphocyte, the entity is the cell type, transplantation strategy or modality itself rather than a single branded cellular product built on the same biology.